Tranexamic acid is a synthetic haemostatic drug that inhibits fibrinolysis. It is effective in reducing bleeding and mortality, although to different extents in trauma, peripartum, and surgical settings. It is generally safe and inexpensive with few adverse reactions, although further studies are needed to assess its safety in settings of high thromboembolic risk.
Efficacy and safety of tranexamic acid in acute haemorrhage
Zaffanello, MarcoMembro del Collaboration Group
;
2024-01-01
Abstract
Tranexamic acid is a synthetic haemostatic drug that inhibits fibrinolysis. It is effective in reducing bleeding and mortality, although to different extents in trauma, peripartum, and surgical settings. It is generally safe and inexpensive with few adverse reactions, although further studies are needed to assess its safety in settings of high thromboembolic risk.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
bmj-2023-075720.full.pdf
accesso aperto
Tipologia:
Documento in Pre-print
Licenza:
Dominio pubblico
Dimensione
1.03 MB
Formato
Adobe PDF
|
1.03 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
